Skip to main content
John Sharretts, MD, Endocrinology, Philadelphia, PA, Philadelphia Veterans Affairs Medical Center

JohnMSharrettsMD

Endocrinology Philadelphia, PA

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, Perelman School of Medicine

Dr. Sharretts is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sharretts' full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1995 - 1999
  • Greater Baltimore Medical Center
    Greater Baltimore Medical CenterInternship, Transitional Year, 1994 - 1995
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1994

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1997 - 2024
  • MD State Medical License
    MD State Medical License 1999 - 2015
  • PA State Medical License
    PA State Medical License 2011 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Press Mentions

  • Wegovy vs. Ozempic: The Truth About These New Weight-Loss Drugs
    Wegovy vs. Ozempic: The Truth About These New Weight-Loss DrugsApril 6th, 2023
  • FDA Approves First Drug to Delay Onset of Type 1 Diabetes
    FDA Approves First Drug to Delay Onset of Type 1 DiabetesNovember 28th, 2022
  • FDA Approves the First Drug That Can Delay the Onset of Type 1 Diabetes
    FDA Approves the First Drug That Can Delay the Onset of Type 1 DiabetesNovember 22nd, 2022
  • Join now to see all

Hospital Affiliations